Idiopathic pulmonary fibrosis: Predicting response to therapy and survival

American Journal of Respiratory and Critical Care Medicine

Volumn 157, Issue 4 PART I, 1998, Pages 1063-1072

  Gay, Steven E ^a   Kazerooni, Ella A ^a   Toews, Galen B ^a   Lynch III, Joseph P ^a   Gross, Barry H ^a   Cascade, Phillip N ^a   Spizarny, David L ^a   Flint, Andrew ^a   Schork, M Anthony ^a   Whyte, Richard I ^a   Popovich, John ^a   Hyzy, Robert ^a   Martinez, Fernando J ^a  

^a TC 3916 ^*

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; FEMALE; HUMAN; IDIOPATHIC DISEASE; IMMUNOSUPPRESSIVE TREATMENT; LUNG FIBROSIS; LUNG FUNCTION; MALE; OPEN LUNG BIOPSY; PREDICTION; PRIORITY JOURNAL; SCORING SYSTEM; STEROID THERAPY; SURVIVAL;

EID: 0031980108     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/ajrccm.157.4.9703022     Document Type: Article

References (20)

1. Raghu, G., W. Depaso, K. Cain, S. Hammar, C. Wetzel, D. Dreis, J. Hutchinson, N. Pardee, and R. Winterbauer. 1991. Azathioprine combined with prednisone in the treatment of idiopathic pulmonary fibrosis: a prospective double-blind, randomized, placebo-controlled clinical trial. Am. Rev. Respir. Dis. 144:291-296.
2. Turner-Warwick, M., B. Burrows, and A. Johnson. 1980. Cryptogenic fibrosing alveolitis: response to corticosteroid treatment and its effect on survival. Thorax 35:593-599.
3. Carrington, C., E. Gaensler, R. Coutu, M. Fitzgerald, and R. Gupta. 1978. Natural history and treated course of usual desquamative interstitial pneumonia. N. Engl. J. Med. 298:801-809.
4. Hartman, T., S. Primack, E. Kang, S. Swensen, D. Hansell, G. McGuinness, and N. Muller. 1996. Disease progression in usual interstitial pneumonia compared with desquamative interstitial pneumonia: assessment with serial CT. Chest 110:378-382.
5. Raghu, G. 1995. Interstitial lung disease: a diagnostic approach: are CT scan and lung biopsy indicated in every patient? Am. J. Respir. Crit. Care Med. 151:909-914.
6. Tukininen, P., E. Taskinen, P. Holsti, O. Korhola, and M. Valle. 1983. Prognosis of cryptogenic fibrosing alveolitis. Thorax 38:349-355.
7. Jezek, V., J. Fucik, A. Michaljanic, and L. Jezkova. 1980. The prognostic significance of functional tests in cryptogenic fibrosing alveolitis. Bull. Europ. Physiopath. Resp. 16:711-720.
8. Schwartz, D., R. Helmers, J. Galvin, D. van Fossen, K. Frees, C. Dayton, L. Burmeister, and G. Hunninghake. 1994. Determinants of survival in idiopathic pulmonary fibrosis. Am. J. Respir. Crit. Care Med. 149:450-454.
9. Johnson, M., S. Kwan, N. Snell, A. Nunn, J. Darbyshire, and M. Turner-Warwick. 1988. Randomized controlled trial comparing prednisolone alone with cyclophosphamide and low dose prednisolone in combination in cryptogenic fibrosing alveolitis. Thorax 44:280-288.
10. Erbes, R., T. Schaber, and R. Loddenkemper. 1997. Lung function tests in patients with idiopathic pulmonary fibrosis: are they helpful for predicting outcome? Chest 111:51-57.
11. van Oortegem, K., B. Wallaert, C. Marquette, P. Ramon, T. Perez, J. Lafitte, and A. Tonnel. 1994. Determinants of response to immunosuppressive therapy in idiopathic pulmonary fibrosis. Eur. Respir. J. 7: 1950-1957.
12. Schwartz, D., D. vanFossen, C. Davis, R. Helmers, C. Dayton, L. Burmeister, and G. Hunninghake. 1994. Determinants of progression in idiopathic pulmonary fibrosis. Am. J. Respir. Crit. Care Med. 149:444-449.
13. Hanson, D., R. Winterbauer, S. Kirtland, and R. Wu. 1995. Changes in pulmonary function test results after 1 year of therapy as predictors of survival in patients with idiopathic pulmonary fibrosis. Chest 108:305-310.
14. Fulmer, J., W. Roberts, E. vonGal, and R. Crystal. 1979. Morphologic-physiologic correlates of the severity of fibrosis and degree of cellularity in idiopathic pulmonary fibrosis. J. Clin. Invest. 63:665-676.
15. Cherniack, R., T. Colby, A. Flint, W. Thurlbeck, J. Waldron, Jr., L. Ackerson, M. Schwarz, and T. King, Jr. 1995. Correlation of structure and function in idiopathic pulmonary fibrosis. Am. J. Respir. Crit. Care Med. 151:1180-1188.
16. Watters, L., T. King, M. Schwarz, J. Waldron, and R. Stanford. 1986. A clinical, radiographic, and physiologic scoring system for the longitudinal assessment of patients with idiopathic pulmonary fibrosis. Am. Rev. Respir. Dis. 133:97-103.
17. Watters, L., M. Schwarz, R. Cherniack, J. Waldron, T. Dunn, R. Stanford, and T. King. 1987. Idiopathic pulmonary fibrosis: pretreatment bronchoalveolar lavage cellular constituents and their relationships with lung histopathology and clinical response to therapy. Am. Rev. Respir. Dis. 135:696-704.
18. Lee, J., J. Im, J. Ahn, Y. Kim, and M. Han. 1992. Fibrosing alveolitis: prognostic implication of ground-glass attenuation at high-resolution CT. Radiology 184:451-454.
19. Muller, N., C. Staples, R. Miller, S. Vedal, W. Thurlbeck, and D. Ostrow. 1987. Disease activity in idiopathic pulmonary fibrosis: CT and pathologic correlation. Radiology 165:731-734.
20. Wells, A., M. Rubens, R. duBois, and D. Hansell. 1993. Serial CT in fibrosing alveolitis: prognostic significance of the initial pattern. A.J.R. 161:1159-1165.